Importantly, PDGFRA (17.3%) and KIT (11.7%) have been found to be the most amplified genes encoding receptor tyrosine kinases (RTK) after EGFR (56%) in a cohort of more than 500 GBM tumors [37]. The gene discussed is EGFR; the disease is glioblastoma.